Painkiller celecoxib slows cancer growth rate
26 May 2016 | By Victoria White, Digital Content Producer
Scientists have found that a widely prescribed painkiller, celecoxib, slows the growth rate of a specific kind of cancer in animal models...
List view / Grid view
News
Pathogen busting bacteriophage found in a pond
26 May 2016 | By Victoria White, Digital Content Producer
A bacteriophage, found in a pond in Connecticut, attacks a common multi-drug resistant bacterial pathogen called Pseudomonas aeruginosa...
Scientists prevent breast cancer cells entering bone marrow
25 May 2016 | By Victoria White, Digital Content Producer
Scientists have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from therapies...
Study finds amyloid-beta acts as natural antibiotic
25 May 2016 | By Victoria White, Digital Content Producer
The findings may lead to new therapeutic strategies and suggest limitations to therapies designed to eliminate amyloid plaques from Alzheimer's patient's brains...
MJFF supports two stem cell projects to speed new Parkinson’s disease therapies
25 May 2016 | By Victoria White, Digital Content Producer
MJFF is to fund two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease...
TwoXAR and University of Chicago in atherosclerosis collaboration
25 May 2016 | By Victoria White, Digital Content Producer
TwoXAR is to collaborate with the Department of Medicine at the University of Chicago to identify potential new medicines for treating atherosclerosis...
Thunderbolt acquires rights to BAFF/APRIL dual antagonist programme
25 May 2016 | By Victoria White, Digital Content Producer
Thunderbolt is the first company established by Vitesse Biologics, a unique collaboration model formed by Baxalta, Mayo Clinic and VPD...
Iceni Pharmaceuticals launches to repurpose cancer therapies
25 May 2016 | By Victoria White, Digital Content Producer
The company’s lead product Cilcane (generic name cilengitide) is being repurposed by Iceni as a first-in-class treatment for multiple myeloma...
The risks of Zika pseudoscientific claims and conspiracy theories
24 May 2016 | By Victoria White, Digital Content Producer
Conspiracy theories and pseudoscientific claims refuting the facts around Zika virus vaccines could be putting people at risk, according to a new study...
TB drug could also target visceral leishmaniasis
24 May 2016 | By Victoria White, Digital Content Producer
Delamanid could also be a powerful tool to combat visceral leishmaniasis researchers at the University of Dundee have found...
Loss of Y chromosome associated with Alzheimer’s disease
23 May 2016 | By Victoria White, Digital Content Producer
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer's disease, according to new research...
Investigating ways to switch on Natural Killer cells
23 May 2016 | By Victoria White, Digital Content Producer
Researchers have identified a protein 'brake' within Natural Killer cells that controls their ability to destroy their target tumour cells...
A simple new platform for antibiotic discovery
23 May 2016 | By Victoria White, Digital Content Producer
Harvard researchers have created a new platform for antibiotic discovery that, they say, may go a long way to solving the crisis of antibiotic resistance...
Stem cell company DefininGEN raises £1.5m in follow-on funding
23 May 2016 | By Victoria White, Digital Content Producer
The new funding will enable DefiniGEN to deliver ground-breaking cryopreserved pancreatic beta cell products to the global diabetes drug development market...
Project to apply crowdsourcing for new treatment approaches for psychiatric diseases
23 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim and BioMed X have established a research team that will conduct research to identify new treatment approaches for psychiatric diseases...
